Phase 3 Stroke Trial, Recruiting (NCT05155137)

Phase 3 Stroke Trial, Recruiting NCT05155137 Sponsor: Hospital Moinhos de Vento Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05155137 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between the ages of 50 and 75 years old
People who have never had a stroke, a mini-stroke (TIA), or heart disease
People whose top blood pressure number (systolic) is between 121 and 139 mmHg
People who have one or more lifestyle risk factors, such as smoking, being overweight (BMI over 25), not getting enough exercise, or having a poor diet (for example, low intake of fruits, vegetables, fish, and whole grains, or high intake of sugary or salty drinks)
People who own or have access to a mobile phone that can receive text messages

Who may not be able to join:

People who have been diagnosed with high cholesterol (LDL above 190 mg/dL) or diabetes, or who are currently taking blood pressure-lowering medications or statins
People who have a medical reason that makes the trial medication unsuitable for them
People whose life expectancy is less than 5 years
People who are already taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Sheila CO Martins, PhD, Hospital Moinhos de Vento

Phone: 5551999628467

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05155137

Sponsor: Hospital Moinhos de Vento

Phase: Phase 3

Status: Recruiting

Condition: Stroke

Trial contact: 5551999628467

More information: https://clinicaltrials.gov/study/NCT05155137

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between the ages of 50 and 75 years old
People who have never had a stroke, a mini-stroke (TIA), or heart disease
People whose top blood pressure number (systolic) is between 121 and 139 mmHg
People who have one or more lifestyle risk factors, such as smoking, being overweight (BMI over 25), not getting enough exercise, or having a poor diet (for example, low intake of fruits, vegetables, fish, and whole grains, or high intake of sugary or salty drinks)
People who own or have access to a mobile phone that can receive text messages

Who may not be able to join:

People who have been diagnosed with high cholesterol (LDL above 190 mg/dL) or diabetes, or who are currently taking blood pressure-lowering medications or statins
People who have a medical reason that makes the trial medication unsuitable for them
People whose life expectancy is less than 5 years
People who are already taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Hospital Moinhos de Vento

Registry

ClinicalTrials.gov

Start date

20 December 2021

Est. completion

14 December 2029

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Stroke; Cognitive decline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov